People who vape regularly show altered activity in 3,124 genes across the genome compared with people who do not smoke or ...
UMSL computer science students in Sharlee Climer’s biological data science course analyze genetic data and network models to ...
Circio Holding has presented preclinical data at ASGCT demonstrating that its circVec circular RNA platform achieved up to 40 ...
Two-year data showed significant functional improvements in patients treated with delandistrogene moxeparvovec compared to controls, despite initial trial endpoint failure. The treated group exhibited ...
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival of approximately 12 months for patients with extensive-stage disease Precede ...
Key opportunities lie in reagents & consumables due to their high usage, drug discovery's large market share, and significant growth in the U.S. market Gene Expression Analysis Market Gene Expression ...
ETX101 reduced seizures and improved neurodevelopmental outcomes, but its impact was unexpectedly attenuated by using the immunosuppressive drug.
RGX-202 met the main goal of a Phase 3 DMD trial, and Regenxbio plans to seek accelerated approval for the gene therapy.
Research Describes the Potential of JCR’s Platform Technologies, Including JUST-AAV Gene Therapy, to Facilitate Delivery of Therapies to the Central Nervous System -HYOGO, Japan--(BUSINESS WIRE)--JCR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results